$TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Healthcare
Sector
Medical - Diagnostics & Research
Industry
Emily Marine Leproust
CEO
923
Employees
$99.84
Current Price
$3.22B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 7 | $5,406,011.10 | 61,547 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 8 | 31 | $13,169,531.87 | 183,027 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 8 | 44 | $15,300,426.64 | 218,693 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Apr 22, 2026 | Leproust Emily M. Director | Sale | 7,910 | $65.28 | $516,325.25 | View Details |
| Apr 21, 2026 | Leproust Emily M. Director | Sale | 1,610 | $65.01 | $104,666.10 | View Details |
| Apr 17, 2026 | Laponis Adam Chief Financial Officer | Sale | 4,000 | $60.00 | $240,000.00 | View Details |
| Apr 14, 2026 | Laponis Adam Chief Financial Officer | Sale | 3,000 | $55.00 | $165,000.00 | View Details |
| Apr 9, 2026 | Laponis Adam Chief Financial Officer | Sale | 2,597 | $49.89 | $129,561.73 | View Details |
97 more transactions available โ create a free account to see 12 months of history | ||||||
Showing 41โ45 of 45 transactions
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history